HealthSmart has been chosen as the independent contractor to provide health care provider network services for the C-8 (PFOA) Medical Monitoring Program (“the Program”). 

In February 2005, the Wood County Circuit Court in West Virginia approved a class action settlement (“the Settlement”) between the Plaintiffs and E.I. du Pont de Nemours and Co. (“DuPont”), the defendant, in a civil class action lawsuit styled Jack Leach, et al. v. E.I. du Pont de Nemours and Co., Civil Action No. 01-C-608 pending in the Circuit Court of Wood County, West Virginia (“the Litigation”). The Litigation involves claims arising from alleged contamination of human drinking water supplies with a chemical known as ammonium perfluorooctanoate (hereinafter “C-8”) attributable to releases from DuPont’s Washington Works Plant in Wood County, West Virginia.

As part of the Settlement, Class Counsel and DuPont selected an independent panel of three epidemiologists (“the Science Panel”) to conduct and evaluate studies to answer the question whether a “Probable Link” exists between exposure to C-8 among Class Members and serious human disease (“Human Disease”). After  lengthy studies, in which many class members participated, the Science Panel found that there is a “Probable Link” between exposure to C-8 and  the following Human Diseases: (1) pregnancy-induced hypertension (including preeclampsia), (2) kidney cancer, (3) testicular cancer, (4) thyroid disease, (5) ulcerative colitis, and (6) diagnosed high cholesterol (hypercholesterolemia).  The Settlement Agreement defines a “Probable Link” to mean that, based upon the weight of the available scientific evidence; it is more likely than not that there is a link between exposure to C-8 and these Human Diseases. The Science Panel did not find that a Probable Link exists for any other Human Diseases.

If you are interested in more information regarding the program or scheduling a webinar, please email providerrelations@healthsmart.com.

Click here for a Program Modification Notice (5-07-2014)